Clinical trial
Intra-arterial Injection of Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis
NCT03516006 is registered in ClinicalTrials.gov with Fuzhou General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intra-arterial Injection of Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis
- Lead sponsor
- Fuzhou General Hospital
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- January 31, 2017
- Completion date
- January 31, 2024
- Enrollment
- 20 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
primary sclerosing cholangitis